Michel Goldman, MD, PhD, is the founder and the President of the I³h Institute and Professor of Immunology and Pharmacotherapy at the Université libre de Bruxelles (ULB). He was the Executive Director of the Innovative Medicines Initiative (IMI) from 2009 to 2014. Previously, he served as Head of the Department of Immunology at Erasme Hospital and was the first Director of the Institute for Medical Immunology (ULB).

Michel Goldman’s scientific achievements resulted in an ISI Highly Cited Scientist nomination in 2006 by the Thomson Institute for Scientific Information. In 1992, Michel Goldman received the Medical Prize Lucien Steinberg (shared with Pr. Peter Piot) and in 2000 the Quinquiennal Prize of the Belgian National Fund for Scientific Research for Clinical Sciences. He held the Francqui Chair at the University of Namur in 1999, at the University of Liège in 2003, and the Spinoza chair at the University of Amsterdam, the Netherlands in 2001. In 2007, Michel Goldman was awarded the degree of Doctor Honoris Causa of the University of Lille, France.

Mathias Dewatripont holds a Ph.D. in Economics from Harvard University (1986). Since 1990, he has been Professor of Economics at ULB affiliated with its Solvay Brussels School of Economics and Management (SBS-EM) and ECARES.
Between 1998 and 2011, he was part-time Visiting Professor at MIT and Research Director of CEPR. Laureate of the 1998 Francqui Prize and of the 2003 Yrjo Jahnsson Prize for Economics, he was a founding member of the Scientific Council of the European Research Council (2007-2012). He is a member of the Académie Royale De Belgique and Foreign Honorary Member of the American Academy of Arts and Science. He is also Honorary Vice-Governor of the National Bank of Belgium, where he served between 2011 and 2017.

He has widely published in the areas of contract theory, organization economics, innovation, and banking and finance. Between April 2020 and March 2022, he was involved in expert groups advising the Belgian authorities on its covid management strategy. In 2023, he was elected Foreign Honorary Member of the American Economic Association.

Hilde Stevens, PhD, senior researcher and lecturer at the I³h Institute, holds the Interfaculty Chair in Health Innovation & Society, supported by the ULB’s Faculty of Medicine and the Solvay Brussels School of Economics and Management (SBS-EM). She coordinates the Interdisciplinary Program in Healthcare Innovation, organized for Master students, PhD students and postdocs from all (Belgian) universities as well as for professionals. She focuses her research on collaborative innovation models, intellectual property (IP) and mechanisms governing access to medicines in the least developed countries (LDCs). Hilde particularly focuses on the governance and performance of public-private partnerships and their added value in the acceleration of innovative therapy development.

Hilde has been Academic Coordinator, Treasurer and Vice-chair in ENP Belgium (2016-2020), the Belgian Patient Platform, supported by EUPATI (European Patients’ Academy on Therapeutic Innovation). There she laid the foundation for her work on patient-centricity.

She holds a Master Degree in Biomedical Science (Ghent University, Belgium), a Master Degree in General Management (Vlerick Business School, Belgium), Master Degree in Intellectual Property (IP) Law (Brussels University, Belgium) and a PhD in Biomedical Sciences from the University of Leuven (Belgium). Hilde worked as a science consultant (Altran) and was a patent engineer for several years (BiIP).

Micael Castanheira is Research Director at the Belgian National Science Foundation. He obtained his Ph.D. in Economics from the ULB. He was a post-doctoral fellow at Bocconi University and a visiting fellow at NYU.

His research focuses mainly on political economics and economic policy, one application of the latter being competition in the pharmaceutical market. He also worked on economic reforms (tax, pensions, institution building). Previously, he acted as an economic expert for a multinational enterprise, for the OECD, and for the World Bank. He sits on the scientific board of the National Bank of Belgium and of the Belgian Price Observatory.

Olivier Vandenberg is the President of the Scientific Committee of the Erasme Fund.
Graduating in medicine from the Université Libre de Bruxelles (ULB) in 1996, Olivier pursued a Master’s degree in Clinical Biology in 2001, followed by a PhD in Biomedical Sciences in 2006. In 2008, he was appointed Head of the Department of Clinical Biology at the network of public university hospitals in Brussels. In 2016, he joined the Division of Infection and Immunity at University College London (UCL) as an Honorary Lecturer. In 2017, he established the Research and Technological Innovation Unit (UNRIT) of the Brussels University Hospital Laboratory (LHUB-ULB), a cross-disciplinary platform aimed at fostering clinical and translational research within Brussels’ university hospitals.
Currently, Olivier is a Professor of Environmental Health at the School of Public Health (ESP) and the Faculty of Medicine at ULB. His research focuses primarily on emerging pathogens and combating antibiotic resistance. Since 2000, he has overseen the consolidation of several microbiology laboratories, enabling the establishment of infectious disease surveillance programs in both industrialized and low- to middle-income countries.
His collaboration with industry in developing new approaches to diagnosing and controlling infectious diseases is particularly noteworthy. His expertise has led him to become a member of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) and the Coordinating Committee for Food- and Waterborne Disease Surveillance Networks of the ECDC since 2014.
With over 200 scientific publications and significant contributions to several book chapters, Olivier is also a member of numerous scientific societies, including the European Society of Clinical Microbiology and Infectious Diseases and the American Society for Microbiology.

Dr. Palina Shauchuk is a Research Manager at Solvay Brussels School of Economics and Management – Université Libre de Bruxelles. She is responsible for planning and supervising research projects, monitoring project progress, supporting team members, implementing new methodologies, and writing reports. Her professional research experience focused on economics and management with a specialisation in RDI and digital industries. Palina obtained her PhD in Applied economics at Université Libre de Bruxelles. She holds two Master’s degrees, one in Marketing at the University of Algarve and another in Economics and Management of National Economy at the Belarusian State University and a Bachelor’s degree in Business Administration at the Belarusian State University.

Caroline joined the Institute as Coordinator of the Educational Program. She started her career in Microfinance and Banking in Africa and Belgium. Most recently, she worked as a project and account manager in a communication agency. Then she gained experience in European Affairs and events management as Partnership Manager for the European Business Summit.

Caroline holds a Master’s degree in International Management with a specialization in Economics of Developing Countries from Ichec Brussels Management School. She is currently enrolled in an second Master’s degree in Population and Development Sciences at ULB.

Florence Horicks is a researcher at I3h Institute and Pôle Santé in ULB. She holds a master’s in biomedical sciences and did a PhD in the Research Laboratory on Human Reproduction under the supervision of Prof. Isabelle Demeestere. She studied the in vitro and in vivo ovarian follicles protection of GnRH analogs in mice exposed to a chemotherapeutic agent. She then coordinated the ULB-Cancer Research Center and conducted an exploratory qualitative study about the needs in oncology in the Brussels-Capital Region. She has been responsible for setting up two transdisciplinary research projects with a large consortium including researchers, healthcare professionals, associative actors, and patients. She coordinated the B.CaRe project, a participative action research project that investigated the humanization of cancer pathways that allowed the first hiring of a Patient Expert in a Belgian hospital. She is partly working in the Pôle Santé for the promotion of participative research and Patient and Public Involvement in health research. She is coordinating a large research project, ONCO.CARE, aiming at building a survivorship program for cancer survivors in Brussels together with HUB, VUB, UZ Brussel, Patient Expert Center and Sciensano. Complementary, she is part of a transdisciplinary team funded by the King Baudouin Foundation to conceptualize and improve Patient Value in oncology research.

Dr. Elise Petit is a post-doctoral fellow and lecturer at Solvay Brussels School of Economics and Management (SBS-EM, ULB). She obtained her Ph.D. in Economics of innovation at Times2 (SBS-EM, ULB), with a particular focus on patent systems. Her teaching activities focus on economics of innovation and econometrics. She holds a bachelor and a master degree in business engineering (SBS-EM, ULB), a master degree in business economics (SBS-EM, ULB), a research master degree in economics and statistics (ECARES, ULB), and a postgraduate certificate in education (AESS, ULB). She is also the co-founder of FratriHa, a non-profit organization that focuses on siblings of individuals with mental disabilities.

Marie Neunez, Ir, is a PhD student at the Faculty of Medicine thanks to the Belgian Kids’ Fund for Pediatric Research and a Master student in medicine at the Université libre de Bruxelles (ULB). Previously she was a part-time research assistant for 3 years at the Institute for Interdisciplinary Innovation in healthcare (I3h). She was a Clinical Research Coordinator for 2 years in the departments of Nuclear Medicine & Radiotherapy at the Institut Jules Bordet (IJB). She also performed a 5-months internship at BASF SE (Mannheim, Germany) in the Human Health & Nutrition department.

Marie holds a MSc degree in bioengineering with a specialization in Science, Technology and Quality of Food (UCL, Belgium), a Postgraduate degree in Management (ICHEC Business Management School, Belgium) and a certificate in Clinical Studies (Cefochim, Belgium).

Sanae Akodad holds a Master’s Degree in Biomedical and specialised during her studies in neurosciences.
She is a research fellow at the Institute for Interdisciplinary Innovation in healthcare where she is achieving a Ph.D. in Biomedical Sciences.
She works as an assistant at the Faculty of Medicine of the Université Libre de Bruxelles. Prior to this, she was a science teacher at the College Saint Pierre.
Her research focuses on health economics and cognitive neurosciences in the field of rare diseases.

Shiri Mermelstein is a PhD candidate at I3h and the Solvay School of Economics and Management. She completed her graduate studies in Global Health at Trinity College Dublin and her undergraduate studies in Cognitive Sciences and Amirim Interdisciplinary Programme in the Humanities at the Hebrew University of Jerusalem.
Prior to her position at I3h, she was a research and teaching assistant at the Centre for Global Health at Trinity College and worked as an analyst for a small consultancy firm in Israel, conducting research for med-tech startups and assisting them in securing innovation and knowledge transfer grants from local and international governmental sources. Previously, she was a clinical research assistant and coordinator for 3 years at the Sagol Brain Institute at Tel Aviv Medical Center. Her current research explores the relationship between innovation policies, alternative IP models and global diffusion and affordability of new and existing health technologies.

Atul Sangith is a PhD candidate at I3h and the Solvay School of Economics and Management. Atul has a background in Pharmaceutical Sciences from Birla Institute of Technology and Science (BITS) Pilani, India and Global Health from Maastricht University, the Netherlands.
Prior to joining I3h, Atul worked as a Program Associate with the global health NGO – PATH, in program planning and implementation of Covid-19 and Digital Health projects in India. He also has research experience in digital health and health promotion through eHealth projects with Nanyang Technological University, Singapore, working on projects in designing healthcare apps and work experience in market research in oncology and antibiotic markets. He has been involved with voluntary health organizations in Tanzania and Nepal in telemedicine and health systems strengthening.
With research interests in access to medicines and healthcare program implementation, Atul’s present research focuses on collaborative models in healthcare to improve access to vaccines in Low-and-Middle Income Countries, particularly in Malaria and Neglected Tropical Diseases.

Xixian Niu is a PhD student at I3h and ECARES (Université libre de Bruxelles). He holds a bachelor’s degree in mathematical statistics from Xiamen University, a joint master’s degree from Paris 1 Panthéon-Sorbonne University and UCLouvain, and is in the process of obtaining a research master’s degree from ECARES.

His research interest lies in the intersection of health economics and industrial organization. He is currently involved in the Hi-Prix project (Health innovation next generation pricing models: Balancing sustainability of innovation with sustainability of health care). His current research focuses on policy analysis on orphan regulation in the EU, orphan drugs’ market and innovation in pharmaceutical industry, e.g., the role of academia, biotech and big pharma companies in the whole development process of medicine.

Sam Daems is a doctoral researcher at I3h Institute. He conducts research on innovative business models to develop therapeutics for ultra-rare diseases, with a specific focus on pediatric oncology. He is a board member of ACCELERATE, a multistakeholder platform in childhood cancer. Furthermore, he is a member of the PROTECT Cancer Grand Challenge team, acting both as a Patient Advocate and workstream lead.

Additionally, Sam is Portfolio Director at Waterland Private Equity where he supports companies in defining and executing their strategy. He holds a Master of Engineering degree from KULeuven, Belgium.

Gaël Libert holds a Master’s Degree in Medicine (ULB) and a Specialized Master in General Medicine (ULB).
He started his research in 2018 and focuses on the “Development of an interdisciplinary model of prescription management in the elderly”. His work is based on field practice, with a predominant use of qualitative studies. The research topics are: improving the quality of prescribing in the elderly, interdisciplinary collaboration around their medication and defining the roles of health care providers in this context.
He also has a Interuniversity Certificate in sports medicine and physiotherapy (ULG/UCL).
His current activities combine general practice and sports medicine, medical research and family planning consulting.